Aker BioMarine ASA (OSL:AKBM)
Norway flag Norway · Delayed Price · Currency is NOK
53.70
+0.50 (0.94%)
Apr 24, 2025, 4:25 PM CET

Aker BioMarine ASA Company Description

Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide.

It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business.

The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name.

The Consumer Health Products segment sells processed and packaged krill, fish, and plants derived raw materials to retailers in the United States.

The Emerging Business segment offers krill oil under Kori brand name. The company provides protein solutions under the Understory brand; biostimulants under KRBNX brand; and a therapeutic candidate based on omega-3 to manage and treat cardiometabolic diseases under CaPre brand name, as well as delivers circular products utilizing recycled industrial and marine plastic waste under AION name.

Aker BioMarine ASA was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.

Aker BioMarine ASA
Country Norway
Founded 2006
Industry Packaged Foods
Sector Consumer Staples
Employees 249
CEO Matts Johansen

Contact Details

Address:
Oksenøyveien 10
Lysaker, 1327
Norway
Phone 47 24 13 00 00
Website akerbiomarine.com

Stock Details

Ticker Symbol AKBM
Exchange Oslo Børs
Fiscal Year January - December
Reporting Currency USD
ISIN Number NO0010886625
SIC Code 0900

Key Executives

Name Position
Seth French Chief Executive Officer of Lang Pharma Nutrition Inc
Simon Seward Chief Executive Officer of Human Health Ingredients
Trond Atle Smedsrud Chief Executive Officer of Emerging Business
Matts Johansen Chief Executive Officer
Katrine Mourud Klaveness Chief Financial Officer
Hege Spaun Chief Officer People and Communication
Christopher Robin Vinter Vice President of IR and Corporate Finance
Tone Lorentzen Chief Operating Officer of Human Health Ingredients
Lise Wiger Financial Controller
Anniken Færgestad Vice President of Finance